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ABSTRACT
Whey, the main by-product of the dairy industry, is 
frequently disposed of in the environment without any 
treatment due to the high cost of this process. Alterna-
tively, whey can be used as a medium to culture lactic 
acid bacteria and produce value-added products such 
as bacteriocins. In this work, we attempted to improve 
bacteriocin production by Lactobacillus plantarum ST-
16Pa in a whey powder formulation supplemented with 
additional sources of carbon, nitrogen, and vitamin B12 
at different levels and varying the agitation intensity 
according to a Plackett–Burman experimental design. 
Only the addition of tryptone positively influenced the 
production of this bacteriocin. The results allowed us to 
identify a supplemented whey formulation, comprising 
150 g/L of whey total solids plus 10 g/L of tryptone and 
soybean extract, whose fermentation by Lb. plantarum 
ST16Pa in shake flasks under agitation at 150 rpm led 
to a cell-free supernatant with an antimicrobial activ-
ity against Listeria innocua 6a CLIST 2865 (inhibition 
zone of 13.23 mm) close to that previously obtained in 
de Man, Rogosa and Sharpe medium by other authors. 
These results are significant considering that the same 
strain cultured in cheese whey did not previously dis-
play any antimicrobial activity.
Key words: whey powder, bacteriocin, Lactobacillus 
plantarum, Plackett–Burman experimental design, 
antimicrobial activity
INTRODUCTION
Whey, the major by-product produced by dairy in-
dustries, is obtained after clotting and casein removal 
during cheese manufacturing (Brandelli et al., 2015). 
For many years, industries sought out cheap disposal 
methods, including discharge into waterways, sewer 
systems, oceans, or fields. These practices have led to 
many environmental problems due to both the high or-
ganic load of whey and its large production (Brandelli 
et al., 2015; Smithers, 2015). When dumped on land 
it causes severe pollution in the surrounding environ-
ment, affecting the physicochemical characteristics of 
soil, hence resulting in decreased crop yields. When 
discharged into water bodies it reduces the dissolved 
oxygen level and hampers biodegradability, which con-
stitutes a risk for aquatic life (González-Siso, 1996).
Today, the disposal of untreated whey in waterways 
is unlawful in most countries (Smithers, 2015); there-
fore, proper management of this by-product is required 
before its discharge (Yadav et al., 2015). Biological 
wastewater treatment is the safest method of whey 
disposal, but it is very expensive (Panesar et al., 2007).
Because whey retains about 55% of total milk nu-
trients (Panesar et al., 2007; Prazeres et al., 2012), 
an economical and advantageous alternative is its use 
as a substrate to produce value-added compounds by 
biological means. Among its most abundant nutrients 
are lactose (75% of DM), soluble proteins (12–14%), 
and lipids and mineral salts (1–10%), which are es-
sential for microbial growth, especially for lactic acid 
bacteria (LAB) (Panesar et al., 2007; Koutinas et al., 
2009; Prazeres et al., 2012). Typically, the production 
of antimicrobial compounds by LAB may be considered 
somewhat expensive. It was estimated that 30% of total 
costs of such a process are related to the culture me-
dium and supplements required to promote the growth 
of the microorganism producing such molecules (Bali et 
al., 2016; Sabo et al., 2017). Considering the aforemen-
tioned whey nutrients, this by-product can mainly be 
considered a cheap carbon source that is able to reduce 
the costs associated with LAB culture medium (Holza-
pfel, 2002). Besides the economic point of view, the use 
of whey as an LAB medium component can be thought 
of as an eco-friendly practice that is able to reduce the 
effects related to its disposal (Panesar et al., 2007).
Lactic acid bacteria are microorganisms widely used 
in food industries to develop meat products, vegetables, 
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and various dairy products (Cintas et al., 2001). Be-
sides playing an important role in food fermentations 
and exerting health benefits to consumers, they are 
known for their ability to produce several biomolecules 
of industrial interest such as bacteriocins (De Vuyst 
and Vandamme, 1994). Bacteriocins are defined as bac-
terially produced, small, heat-stable peptides that are 
active against other bacteria and to which the producer 
possesses a specific immunity mechanism (Cotter et al., 
2005). Although bacteriocins can be produced by many 
microorganisms, those produced by LAB have received 
increased attention over the past decades because they 
are considered to be “generally recognized as safe” mi-
croorganisms (Balciunas et al., 2013).
Among LAB, Lactobacillus is the largest genus, com-
prising more than 150 species (Siezen et al., 2010). The 
species Lactobacillus plantarum can adapt to various 
niches due to its ability to ferment a wide range of car-
bohydrates (Sabo et al., 2014). Particularly, the strain 
Lb. plantarum ST16Pa was reported to produce a 6.5-
kDa peptide exhibiting antimicrobial activity against 
many different foodborne pathogenic bacteria, includ-
ing gram-negative ones (Todorov et al., 2011; Sabo et 
al., 2015). Moreover, a PCR analysis of Lb. plantarum 
ST16Pa DNA evidenced the presence of nisin and en-
terocin P genes, but this detection does not guarantee 
that the strain expresses 1 of these 2 bacteriocins or 
even a combination of them (Todorov et al., 2014).
Although whey can support the growth of most LAB 
(Brinques et al., 2010; Panesar et al., 2010; Ünlü et al., 
2015), it is lacking in nitrogen and other nutritional 
components, often requiring their supplementation to 
satisfactorily sustain bacteriocin production (Briczinski 
and Roberts, 2002). Moreover, some LAB have an inef-
ficient proteolytic system and are highly dependent on 
external supplements to synthesize peptides and pro-
teins (Ummadi and Curic-Bawden, 2010; Pleissner and 
Venus, 2016). In a previous study, Todorov et al. (2011) 
demonstrated the ability of the strain Lb. plantarum 
ST16, when cultivated in de Man, Rogosa and Sharpe 
(MRS) broth supplemented with different nutrients, to 
produce a bacteriocin with high antimicrobial activity 
against several microorganisms. However, when cul-
tured in cheese whey, despite the satisfactory biomass 
production, this strain did not produce bacteriocin.
Based on this background, the aim of this study was 
to check the ability of Lb. plantarum ST16Pa to produce 
bacteriocin in a medium based on whey, with the aim 
of making its production profitable from an economic 
point of view. To find the best production conditions, 
different whey powder formulations supplemented with 
additional sources of carbon, nitrogen, and vitamin B12 
were tested at different concentrations and different 




This study was conducted with the probiotic bacterio-
cin-producing strain Lb. plantarum ST16Pa previously 
isolated by Todorov et al. (2011) from papaya. The 
bacteriocin produced by this strain is referred to here 
as “bacteriocin ST16Pa.” The strain Listeria innocua 
6a CLIST 2865 (AL230/07), isolated from a sausage 
sample and provided by Coleção de Listeria of Funda-
ção Oswaldo Cruz (FioCruz, Rio de Janeiro, Brazil), 
was used as an indicator microorganism susceptible to 
bacteriocin antimicrobial activity.
Lactobacillus plantarum ST16Pa and L. innocua 6a 
CLIST 2865 were cultured in MRS and brain heart 
infusion (BHI) broths, respectively, both provided by 
Difco (Detroit, MI), incubated at 30°C on an orbital 
shaker at 100 rpm for 24 h and then cryopreserved 
after addition of 20% (vol/vol) glycerol. Finally, the 
cryopreserved strains were stored at −70°C.
Experimental Design to Improve Bacteriocin  
ST16Pa Production
A PB experimental design matrix was used to identi-
fy the best medium composition and agitation intensity 
for bacteriocin production by Lb. plantarum ST16Pa 
in whey powder–based medium. Such an experimental 
design is a 2-level partial factorial design often used 
to identify significant factors for further investigation 
(Kennedy and Krouse, 1999). According to these au-
thors, it is a method especially suited to investigate 
the simultaneous effects of many factors and to cheaply 
optimize medium composition and culture conditions 
in fermentation processes through a minimal number 
of experiments.
For that, 8 variables—whey powder TS content; 
concentrations of inulin, sucrose, glucose, soybean 
extract, tryptone, and vitamin B12; and agitation in-
tensity—were screened at 3 levels in 12 triplicate runs, 
plus 4 triplicate repetitions of the central point. The 
minimum, central, and maximum levels selected for 
these variables are listed in Table 1, where columns 
represent the levels of each independent variable and 
rows represent the conditions of each run. Lactobacillus 
plantarum ST16Pa dry cell mass concentration after 
48 h of cultivation and the mean diameter of inhibi-
tion zone against the bioindicator strain were used as 
the response variables. Variables with confidence levels 
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>95% were considered to have a significant influence on 
inhibition zones induced by bacteriocin ST16Pa.
The choice to supplement whey powder with glucose 
(Inlab, São Paulo, Brazil), sucrose (Cromoline Química 
Fina, São Paulo, Brazil), tryptone (Difco) and vita-
min B12 (Inlab) was based on the study of Todorov 
et al. (2011). Additionally, we tested inulin (Clariant, 
São Paulo, Brazil) because of its well-known ability to 
improve the growth of probiotic bacteria. To improve 
bacteriocin ST16Pa antimicrobial activity, we used soy-
bean extract (Jasmine, Curitiba, Brazil). The addition 
to whey of this extract as a nitrogen source is expected 
to be especially advantageous.
Whey Preparation
Whey powder, kindly provided by BR Foods (São 
Paulo, Brazil), was used to carry out this study. Ac-
cording to this company, 26 g of sweet powder whey 
comprised 20 g of carbohydrates, 2.9 g of proteins, 0.6 
g of total fats, 0.5 g of saturated fats, 0.14 g of calcium, 
and 0.22 g of sodium.
Whey was prepared using different concentrations 
of TS and diluted in distilled water. According to the 
methodology of Vignolo et al. (1995) and Guerra and 
Pastrana (2001), the whey-based solution was acidified 
to pH 4.0 by the addition of 10 M HCl and heated 
at 100°C for 30 min in a thermal bath to denature 
proteins and remove insoluble compounds. The result-
ing solution was centrifuged, and the supernatant was 
adjusted at pH 6.3 using 10 M NaOH and subsequently 
supplemented with carbon, nitrogen, and vitamin B12 in 
accordance with the above-mentioned PB experimental 
matrix. Finally, it was pasteurized at 90°C for 5 min in 
a thermal bath and subsequently cooled in an ice bath 
for 10 min.
Inoculum Preparation and Culture Conditions
Lactobacillus plantarum ST16Pa inoculum was pre-
pared by adding 1.0 mL of culture stock (stored at 
−70°C, for a maximum period of 90 d) to 250-mL Er-
lenmeyer flasks containing 100 mL of MRS broth and 
incubated in an orbital shaker at 30°C at 100 rpm for 
12 h. Then, the fermented medium was diluted with 
sterile distilled water up to a final concentration of 0.8 
to 0.9 optical density units at 650 nm. Ten milliliters 
of this diluted inoculum [10% (vol/vol) of the final 
working volume] was centrifuged at 4,470 × g for 15 
min at 4°C. The resulting pellet was washed twice with 
sterile distilled water and resuspended directly in 10 
mL of the previously treated and supplemented whey 
solution. The cell washing procedure was adopted to 
eliminate any MRS residues that could have caused 
a false-positive bacteriocin production. Finally, the 
resuspended inoculum was transferred into 250-mL Er-
Table 1. Plackett–Burman experimental design matrix used to identify the best medium composition and agitation intensity for the production 






concentration (g/L)X1 X2 X3 X4 X5 X6 X7 X8
1 +1 −1 +1 −1 −1 −1 +1 +1 0 0.36 ± 0.00bc
2 +1 +1 −1 +1 −1 −1 −1 +1 0 0.31 ± 0.06b
3 −1 +1 +1 −1 +1 −1 −1 −1 0 0.58 ± 0.02ef
4 +1 −1 +1 +1 −1 +1 −1 −1 11.82 ± 0.02bc 0.68 ± 0.01f
5 +1 +1 −1 +1 +1 −1 +1 −1 0 0.32 ± 0.07b
6 +1 +1 +1 −1 +1 +1 −1 +1 11.56 ± 0.03ab 1.63 ± 0.00h
7 −1 +1 +1 +1 −1 +1 +1 −1 12.00 ± 0.23c 0.93 ± 0.03g
8 −1 −1 +1 +1 +1 −1 +1 +1 0 0.43 ± 0.03bcd
9 −1 −1 −1 +1 +1 +1 −1 +1 11.37 ± 0.02a 0.88 ± 0.03g
10 +1 −1 −1 −1 +1 +1 +1 −1 13.23 ± 0.04d 1.75 ± 0.12h
11 −1 +1 −1 −1 −1 +1 +1 +1 11.36 ± 0.29a 0.51 ± 0.04de
12 −1 −1 −1 −1 −1 −1 −1 −1 0 0.17 ± 0.00a
13 0 0 0 0 0 0 0 0 11.38 ± 0.16a 0.50 ± 0.03de
14 0 0 0 0 0 0 0 0 11.53 ± 0.04ab 0.41 ± 0.03bcd
15 0 0 0 0 0 0 0 0 11.58 ± 0.04ab 0.49 ± 0.01de
16 0 0 0 0 0 0 0 0 11.49 ± 0.10a 0.46 ± 0.03cde
a–hDifferent superscripts within in the same column mean that values significantly differ (P < 0.05).
1The results are expressed as Lb. plantarum ST16Pa dry cell concentration after 48 h of cultivation (g/L) and main diameter of inhibition zone 
against Listeria innocua 6a CLIST 2865 (mm) as the bioindicator strain.
2The coded levels +1, 0, and −1 refer to the highest, central, and lowest levels of variables. X1 = whey powder TS content: 150, 100, and 50 g/L; 
X2 = inulin concentration: 20, 10, and 0 g/L; X3 = sucrose concentration: 30, 15, and 0 g/L; X4 = glucose concentration: 30, 15, and 0 g/L; X5 
= soybean extract concentration: 10, 5, and 0 g/L; X6 = tryptone concentration: 10, 5, and 0 g/L; X7 = vitamin B12 concentration: 1.6, 0.8, and 
0 mg/L; X8 = agitation intensity: 150, 100, and 50 rpm. Mean values (n = 3) ± SD. 
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lenmeyer flasks containing 90 mL of previously treated 
and supplemented whey powder.
All the cultures were performed in triplicate, incu-
bating the flasks at 30°C for 48 h in an orbital shaker at 
the selected agitation intensity. Samples were collected 
after this period to determine Lb. plantarum dry cell 
mass concentration and measure the inhibition zones 
induced by bacteriocin ST16.
Scaling Up in Bioreactor  
and Fermentation Parameters
Based on the results of runs carried out in flasks 
according to the PB experimental design, the supple-
mented whey powder formulation that ensured the 
best performance was scaled up to a 2-L stirred tank 
bioreactor (Biostat B plus Sartorius, Göttingen, Ger-
many). For this purpose, 0.9 L of medium containing 
such supplemented whey powder was transferred to the 
tank, and subsequently 100 mL of inoculum suspension 
was added. Cultures were conducted in triplicate under 
conditions as much as possible coincident with those 
performed in shake flasks.
Samples were collected every 2 h during 12 h and 
then after 24 and 48 h of fermentation and were ana-
lyzed for Lb. plantarum ST16Pa dry cell concentration, 
mean diameter of inhibition zone induced by bacterio-
cin ST16Pa, and lactate and lactose concentrations. 
These experimental data were then used to calculate 
the main fermentation parameters such as the yields of 
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where Xf and Xi are the final and initial biomass con-
centrations, Sf and Si are the final and initial lactose 
concentrations, PLACf and PLACi are the final and initial 
lactate concentrations, and Tf and Ti are the final and 
initial times. To evaluate the reproducibility of run in a 
bioreactor, these parameters were compared with those 
obtained in runs carried out in shake flasks under com-
parable conditions using the same supplemented whey 
powder formulation.
Determination of Lactose  
and Lactate Concentrations
To determine the concentrations of lactose and lac-
tate, samples were aseptically collected and centrifuged 
at 3,421 × g for 15 min. The supernatant was filtered 
through membranes with 0.22-μm pore diameter (Mil-
lipore, Bedford, MA) and analyzed using an HPLC de-
vice (Ultimate 3000, Dionex, Sunnyvale, CA) equipped 
with a refractive index detector (Shodex RI-210, Ka-
wasaki, Kanagawa, Japan) and an HPX-87H column 
(Bio-Rad, Hercules, CA). Analyses were carried out at 
50°C using 5.0 mM H2SO4 as mobile phase at a flow 
rate of 0.6 mL/min. High-purity lactose and lactate 
(Sigma-Aldrich, St. Louis, MO) were used at concen-
trations from 0.1 to 10.0 g/L as standard solutions to 
prepare the corresponding calibration curves.
Cell Growth
The growth of Lb. plantarum ST16Pa was monitored 
by counting colony-forming units per milliliter using 
the serial dilution technique, in which 0.5 mL of the 
sample was serially 10-fold diluted in 4.5 mL of 0.85% 
(wt/vol) sterile saline. Subsequently, 100 μL of each 
dilution was transferred to Petri dishes (90 × 15 mm) 
containing MRS broth gelled with 1.5% (wt/vol) agar. 
With the aid of a sterile Drigalski handle, the diluted 
samples were spread over the surface of the medium, 
and the plates were incubated for 48 h. Only plates 
containing 30 to 300 colonies were considered. Each 
count determination was performed in triplicate, and 
the results were expressed as mean values.
To convert colony-forming units per milliliter to cell 
dry concentration (g/L), Lb. plantarum ST16Pa was 
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cultivated in MRS broth and incubated in an orbital 
shaker at 30°C and 100 rpm. To this purpose, a calibra-
tion curve described by the equation y = 8.107 x − 1.107 
(R2 = 0.98) was obtained by plotting the colony-form-
ing units per milliliter values versus the corresponding 
dry cell mass concentrations obtained by filtration of 
cell-containing MRS broth through membranes with a 
0.22-μm pore diameter (Millipore).
Bacteriocin Antimicrobial Activity Assay
Bacteriocin ST16Pa antimicrobial activity was deter-
mined in triplicate, according to the spot-on-the-lawn 
method (van Reenen et al., 1998), on cell-free superna-
tants (CFS) of broth samples previously centrifuged at 
25,750 × g at 4°C for 10 min, and pH was adjusted to 
6.0 with 1.0 M NaOH. Petri dishes containing 10 mL of 
melted BHI soft agar [supplemented with 0.75% agar 
(wt/vol)] were previously inoculated with 1.0 mL of a 
100-fold-diluted overnight-aged suspension of the bioin-
dicator microorganism (approximately 108 cfu/mL). It 
is noteworthy that such a low agar concentration was 
selected based on previous observation that high agar 
concentrations, responsible for an increased matrix 
density, affected the diameter of the inhibition zone, 
slowing down the diffusion of the bacteriocin molecules 
(Blom et al., 1997).
After agar gelation, 20 μL of CFS was dropped onto 
the BHI soft agar surface and incubated at 30°C for 
24 h. Next, the diameters of the bacteriocin-induced 
inhibition zones were measured by means of a digital 
caliper (model 684132; Lee Tools, São Paulo, Brazil) in 
4 different directions and expressed as mean values in 
millimeters.
The antimicrobial activity of CFS from whey pow-
der formulations that ensured the largest bacteriocin 
ST16Pa inhibition zones was also quantified by serial 
2-fold dilutions in 25 mM phosphate buffer at pH 6.5. 
The concentration of bacteriocin produced by Lb. plan-
tarum ST16Pa was expressed in arbitrary units (AU) 
per milliliter by the equation
 AU/mL = Dn × 1,000/P, [7]
where D = dilution factor, n = first dilution showing no 
inhibition zone, and P = volume (μL) of supernatant 
spread onto the agar surface.
Inhibition Zones Stability
To check whether the bacteriocin produced in the 
supplemented whey powder formulation that ensured 
the best performance had the same protein nature and 
stability as that described by Todorov et al. (2011) cul-
turing Lb. plantarum ST16Pa in MRS broth, the effects 
of digestive enzymes, chemicals, and temperature on the 
inhibition zones were also investigated. To this purpose, 
the pH of CFS from bioreactor broths was adjusted 
to 6.0 with 1.0 M NaOH, and 1.0-mL aliquots were 
incubated at 30°C for 2 h in the presence of 1.0, 5.0, or 
30 mg/mL of chymotrypsin, trypsin, protease XIV, and 
α-amylase (all purchased from Sigma-Aldrich). Addi-
tional 1.0-mL aliquots of CFS were individually treated 
with 1.0% (wt/vol) SDS (Inlab), urea (Synth, São 
Paulo, Brazil), EDTA (Inlab), or NaCl (Synth) or with 
1.0% (vol/vol) Triton X-100 (Inlab), Tween 20 (Inlab), 
or Tween 80 (Inlab) and then incubated at 30°C for 1 
h. The effect of temperature on the inhibition zones 
was investigated by heating CFS in a thermoregulated 
bath at 40, 60, 80, and 100°C for 1 h and at 121°C for 
20 min. All the samples were tested for antimicrobial 
activity against the bioindicator strain L. innocua 6a 
CLIST 2865 according to the spot-on-the-lawn method 
described above. Untreated CFS served as controls.
Effect of Bacteriocin ST16Pa on the Growth  
of the Bioindicator Microorganism
A 4.5-mL aliquot of CFS from the bioreactor broth 
was added to 100-mL Erlenmeyer flasks containing 30.5 
mL of BHI broth previously inoculated with 0.35 mL 
of an overnight-aged L. innocua 6a CLIST 2865 suspen-
sion. The control assay was carried out under the same 
conditions described above but without CFS. Then, the 
flasks were incubated at 37°C in an orbital shaker at 
100 rpm for 6 h. Optical density measurements at 600 
nm were recorded every hour.
Bacteriocin-Induced Reduction of Bioindicator 
Microorganism Viability
The pellet resulting from centrifugation at 4,470 × 
g at 4°C for 15 min of an overnight-aged culture of L. 
innocua 6a CLIST 2865 was washed twice with 0.85% 
(wt/vol) sterile saline solution and resuspended in 10 
mL of the same solution. An equal volume of CFS from 
the bioreactor was mixed with the resuspended pellet, 
and the number of viable cells was counted, either be-
fore or after incubation at 37°C for 1 h, by plating these 
solutions onto BHI broth supplemented with 1% (wt/
vol) agar and incubating the plates at 37°C for 48 h. 
Cell suspensions of the bioindicator strain without CFS 
served as controls.
Purification of Bacteriocin ST16Pa
The pH of a 100-mL aliquot of CFS from the bio-
reactor was adjusted to 6.0 with 1.0 M NaOH and 
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was subsequently used for further assays. Bacteriocin 
ST16Pa was precipitated by adding ammonium sulfate 
to CFS in order to obtain 30% (wt/vol) saturation and 
then stirred at 4°C for 2 h. The pellet resulting from 
centrifugation at 4,470 × g at 4°C for 30 min was resus-
pended in 10 mL of 25 mM ammonium acetate buffer 
(pH 6.5) and loaded on a previously activated C18 solid 
phase extraction (SPE) cartridge (model Oasis HLB; 
Waters, Millipore), which was eluted with isopropanol 
solutions in the same buffer with gradually increasing 
concentration [20, 40, 60, and 80% (vol/vol)]. To con-
trol and validate the proposed protocol, Lb. plantarum 
ST16Pa was cultured in MRS broth at 30°C for 24 h, 
and the resulting CFS was treated as previously de-
scribed.
The antimicrobial activity was tested against L. in-
nocua 6a CLIST 2865 by the spot-on-the-lawn method 
as previously described. The protein concentration 
after each step was determined using the BCA pro-
tein assay reagent (Sigma-Aldrich) as specified by the 
manufacturer and a calibration curve (y = 0.0011 x 
+ 0.00245; R2 = 0.99). It was possible to determine 
the total antimicrobial activity (AU), specific activity 
(AU/mL), yield (%), and purification fold.
Statistical Analysis
The results of cultures performed according to the 
PB experimental design matrix were analyzed using 
Minitab 17 Statistical Software (Minitab Inc., State 
College, PA) and statistically worked out by ANOVA.
RESULTS AND DISCUSSION
Bacteriocin ST16Pa Production in Shake Flasks
The individual effects of whey powder TS content, 
agitation intensity, and concentrations of tryptone, su-
crose, soybean extract, glucose, vitamin B12, and inulin 
on Lb. plantarum ST16Pa cultures were investigated in 
shake flasks at 30°C according to a PB experimental 
design. The results of these runs collected after 48 h are 
listed in Table 1 in terms either of mean diameters of 
inhibition zones against L. innocua 6a CLIST 2865 as 
a bioindicator strain or of Lb. plantarum ST16Pa dry 
cell concentration.
An additional control run was performed out of the 
PB experimental matrix by culturing Lb. plantarum 
ST16Pa on nonsupplemented whey powder under the 
same conditions as those of the central point of the 
experimental design (100 g/L of total whey solids 
content, 30°C, 100 rpm). Even though the strain was 
able to slightly grow under these conditions (0.22 g/L), 
the broth CFS did not display any antimicrobial activ-
ity, thus confirming the observations of Todorov et al. 
(2011) on the same strain grown on cheese whey (20 or 
100 g/L of TS) as a fermentation substrate.
On the other hand, 10 of the 16 whey powder formu-
lations tested according to the PB experimental matrix 
allowed for considerably higher growth of Lb. planta-
rum ST16Pa and satisfactory bacteriocin ST16Pa anti-
microbial activity (runs 4, 6, 7, 9, 10, 11, and 13–16). 
Taking all the runs as a whole, both biomass concen-
tration and mean diameter of inhibition zones varied 
markedly (from 0.17 to 1.75 g/L and from 0.00 to 13.23 
mm, respectively), hence highlighting the importance 
of optimizing the medium to enhance bacteriocin pro-
duction.
The Pareto chart illustrated in Figure 1 shows that 
only the addition of tryptone as a medium supplement 
led to a statistically significant increase in the mean 
diameter of the inhibition zone induced by bacteriocin 
ST16Pa (at a 95% confidence level). In fact, irrespec-
tive of tryptone concentration, all the CFS of culture 
broths in which this compound was used as an ingredi-
ent displayed inhibition zones up to 11.00 mm, and 
when tryptone was not used as a supplement no anti-
microbial activity was observed (Table 1).
Todorov et al. (2011) also reported an increase in 
bacteriocin ST16Pa activity from 25,600 to 51,200 
AU/mL when Lb. plantarum ST16Pa was cultured in 
MRS broth supplemented with 20 g/L of tryptone. Our 
results also agree with those reported for sakacin P 
production by Lactobacillus sakei CCUG 42687 (Aasen 
et al., 2000), for bacteriocin ST341LD produced by Lb. 
plantarum ST341LD (Todorov and Dicks, 2005), and 
recently for bacteriocins produced by Lactococcus lactis 
19.3 and Enterococcus durans 41.2 (Zamfir et al., 2016). 
This occurrence may be ascribed to the fact that tryp-
tone serves as a source of various AA that are essential 
for the biosynthesis of bacteriocin or even act as its 
inducers (Cabo et al., 2001).
After analyzing the Pareto chart, we decided to carry 
out additional runs at 30°C and 100 rpm for 48 h in 
250-mL Erlenmeyer flasks containing 100 mL of broth 
based on a whey powder formulation comprising 150 
g/L of TS supplemented with tryptone as the sole ingre-
dient at different concentrations (3, 10, or 17 g/L). The 
CFS from these samples did not show any inhibition 
zone, likely due to some drawback inherent to the PB 
experimental design—that is, it does not allow knowing 
whether the effect of one factor depends on another 
factor or assumes that the most important effects are 
much larger than 2-factor interactions (Montgomery 
et al., 1997). Moreover, according to Myer and Mont-
gomery (2002), the main effects can be confused with 
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second-order interactions, and second-order interac-
tions can be confused with each other. Based on these 
considerations, we suspect that the improved inhibition 
zones obtained in this work in the presence of tryp-
tone may have been due also to another independent 
variable, which could not be identified because of the 
features of the selected experimental design. Therefore, 
the subsequent study in the bioreactor was performed 
using the whey powder formulation that ensured the 
largest bacteriocin ST16Pa inhibition zone (13.23 mm) 
and the highest biomass concentration (1.75 g/L; run 
10), although bacteriocin ST16Pa production seemed 
not to be strictly associated with the microbial growth 
(Figure 2).
According to Kim et al. (1997) and Bogovič-Matijašić 
and Rogelj (1998), bacteriocin production is strongly 
dependent on pH, nutrient sources, and incubation 
temperature, but the activity levels are not always 
related to the cell mass concentration or growth rate 
of the producing strain. In addition, an increase in bac-
teriocin production can occasionally be obtained under 
suboptimal conditions (De Vuyst et al., 1996).
Culture in Bioreactor and Kinetic Parameters
The conditions and whey powder formulation compo-
sition of run 10, which ensured the best performance in 
shake flasks (Table 1), were adopted to carry out a cul-
tivation in a 2.0-L bioreactor. As can be seen in Table 
2, there were no considerable differences between the 
values of biomass concentration, bacteriocin ST16Pa 
activity expressed in arbitrary units per milliliter, lac-
tate concentration, and main fermentation parameters 
in shake flasks and bioreactor.
Effect of Proteolytic Enzymes, Chemicals,  
and Temperature on Bacteriocin ST16Pa 
Antimicrobial Activity
The CFS from bioreactor-fermented broth (supple-
mented whey powder formulation that ensured the best 
performance; run 10) was used to evaluate the effects 
of proteolytic enzymes, chemicals, and temperature on 
bacteriocin antimicrobial activity. The results of these 
tests, expressed in terms of inhibition zone diameter 
(Table 3), should be evaluated by comparing them with 
the CFS without any treatment (13.23 mm).
The CFS treated with 1.0, 5.0, and 30.0 mg/mL of 
chymotrypsin, trypsin, and protease XIV resulted in 
complete inactivation of bacteriocin ST16Pa antimi-
crobial activity against the bioindicator strain. When 
treated with 1.0 mg/mL of α-amylase, the inhibition 
zone had a diameter (13.00 mm) only 2% shorter than 
that of the CFS without any treatment, whereas it was 
completely suppressed when higher concentrations of 
the same enzyme (5.0 and 30.0 mg/L) were used. Fig-
ure 3 shows that, when the CFS was treated with 30.0 
mg/mL of all the enzymes, the inhibition zones, usually 
circular, became deformed.
Despite the loss of antimicrobial activity at high 
α-amylase concentration, our results corroborate with 
those of Todorov et al. (2011), who reported no effect of 
1.0 mg/mL of this enzyme on bacteriocin ST16 stabil-
ity. Taking into account that α-amylase is produced 
Figure 1. Pareto chart showing the individual effects, according to the Plackett–Burman experimental design, of whey powder TS content, 
agitation intensity, and concentrations of tryptone, sucrose, soybean extract, glucose, vitamin B12, and inulin on bacteriocin ST16Pa antimicro-
bial activity against Listeria innocua 6a CLIST 2865.
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by salivary glands and its main function is to initiate 
starch digestion (Cardoso et al., 2017), we also agree 
with the suggestion of Todorov et al. (2011) that bac-
teriocin ST16Pa does not belong to the controversial 
group IV of bacteriocins, which contain carbohydrates 
or lipids in the active molecule structure. Keppler et 
al. (1994) and Seo et al. (2014) also related partial or 
total loss of bacteriocins antimicrobial activity when 
the CFS was treated with α-amylase, likely due to the 
hydrolysis of a carbohydrate moiety, which is essential 
for their activity. However, this effect was observed 
with α-amylase concentrations of 1.0 and 0.1 mg/mL, 
respectively, which are much lower than that used in 
the present work (5 mg/mL), thus suggesting a quite 
different behavior.
Regarding the effect of chemicals, Tween 20, Tween 
80, NaCl, urea, and EDTA did not significantly influ-
ence the inhibition zones. Similar stability was ob-
served for the same bacteriocin produced in MRS broth 
(Todorov et al., 2011). On the other hand, SDS led to 
a 20% increase and Triton X-100 to a 23% reduction of 
the inhibition zone diameter. A similar negative effect 
of Triton X-100 on bacteriocin stability was reported 
by Todorov and Dicks (2005), a possible cause of which 
may have been the interaction of this uncharged sur-
factant with the bacteriocin that may have changed its 
tertiary structure to a less active form. On the other 
hand, the positive effect of SDS may be simply ascribed 
to the slight antimicrobial activity of this detergent 
that, when diluted in sterile water up to 1% (wt/vol) 
Figure 2. Lactobacillus plantarum ST16Pa dry cell concentration (gray bars) and mean diameter of inhibition zone (white bars). Run num-
bering is the same as that of the Plackett–Burman experimental design in Table 1.
Table 2. Comparison of the results of Lactobacillus plantarum ST16Pa cultures carried out in shake flasks and 
bioreactor on the whey powder formulation of run 10 according to the Plackett–Burman experimental design 
(Table 1)
Item1 Shake flask Bioreactor
Biomass concentration (g/L) 1.50 1.56
Bacteriocin ST16Pa activity (AU/mL) 1,600 1,600
Lactate concentration (g/L) 8.85 8.61
µmax (h
−1) 0.48 0.48
Tg (h) 1.44 1.44
Qlactate (g/L per hour) 0.18 0.18
Qbiomass (g/L per hour) 0.03 0.03
Ybiomass/lactose (g/g) 0.08 0.07
Ylactate /lactose (g/g) 0.46 0.39
1µmax = maximum specific growth rate; Tg = generation time; Ybiomass/lactose = biomass yield on consumed lac-
tose; Ylactate/lactose = lactate yield on consumed lactose; Qbiomass = overall biomass volumetric productivity; Qlactate 
= overall lactate volumetric productivity. Fermentation parameters were estimated after 48 h of cultivation.
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and used as a control, induced a 5.0-mm inhibition zone 
against L. innocua 6a CLIST 2865, resulting in a syn-
ergistic effect of the bacteriocin ST16Pa antimicrobial 
activity. The same occurrence was noticed by Azhar et 
al. (2017), but in this case the authors reported that 
SDS caused disaggregation of large molecules present 
Table 3. Characterization of bacteriocin ST16Pa from bioreactor cell-free supernatants (obtained from the supplemented whey powder 
formulation corresponding to run 10) in terms of effects of proteolytic enzymes, chemicals, and temperature on the diameter of inhibition zones 
against Listeria innocua 6a CLIST 28651
Stability  Concentration  
Inhibition zone diameter 
in this study2 (mm)  
Activity of bacteriocin ST16Pa 
in Todorov et al. (2011)3
Enzyme    
 Chymotrypsin 1 mg/mL (wt/vol) − −
 Trypsin 1 mg/mL (wt/vol) − −
 Protease XIV 1 mg/mL (wt/vol) − NT4
 α-Amylase 1 mg/mL (wt/vol) +++ +
 Chymotrypsin 5 and 30 mg/mL (wt/vol) − NT
 Trypsin 5 and 30 mg/mL (wt/vol) − NT
 Protease XIV 5 and 30 mg/mL (wt/vol) − NT
 α-Amylase 5 and 30 mg/mL (wt/vol) − NT
Temperature    
 40°C/1 h  +++ +
 60°C/1 h  +++ +
 80°C/1 h  +++ +
 100°C/1 h  ++ +
 121°C/20 min  + +
Chemical5    
 Triton X-100 1% (vol/vol) + +
 Tween 20 1% (vol/vol) +++ +
 Tween 80 1% (vol/vol) +++ +
 SDS 1% (wt/vol) ++++ +
 NaCl 1% (wt/vol) +++ +
 Urea 1% (wt/vol) +++ +
 EDTA 1% (wt/vol) +++ +
1The effect was compared with that reported by Todorov et al. (2011), who tested bacteriocin ST16Pa activity against Enterococcus faecalis 
ATCC 19443.
2Inhibition zone diameter: ++++, >14.0 mm; +++, 12.5–13.9 mm; ++, 11.0–12.4 mm; +, 10.0–10.9 mm; −, no inhibition zone.
3These authors did not report the inhibition zone diameter but rather only the presence (+) or not (−) of inhibition zones.
4Not tested.
5Triton X-100, Tween 20, Tween 80, SDS, and EDTA were from Inlab (São Paulo, Brazil), the NaCl and urea were from Synth (São Paulo, 
Brazil).
Figure 3. Effect of 30 mg/L of proteolytic enzymes on inhibition zones induced by cell-free supernatant from Lactobacillus plantarum 
ST16Pa culture in bioreactor.
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in the tested cell-free supernatant, resulting in a signifi-
cant increase in antimicrobial effects.
The inhibition zones induced by bacteriocin ST16Pa 
also remained stable after 1 h of treatment at 40, 60, 
and 80°C and suffered only a slight shortening upon 
heat treatment at 100°C for 1 h (by 15%) or at 121°C 
for 20 min (by 19%). Such heat stability, which is con-
sistent with the results reported for several bacteriocins 
produced by different strains of Lb. plantarum (Lee and 
Paik, 2001; Wen et al., 2016), would be a very useful 
feature for a food preservative, considering that many 
food-processing procedures involve a heating step (Xie 
et al., 2011).
Antimicrobial Mode of Action of Bacteriocin ST16Pa 
Against the Bioindicator Strain
The CFS from bioreactor-fermented broth dramati-
cally inhibited the L. innocua 6a CLIST 2865 growth, 
exhibiting an optical density value at 650 nm after 6 
h of cultivation (0.39) that was much lower than the 
control (1.72; Figure 4). When the overnight-aged cells 
of the bioindicator strain were put in contact with the 
same CFS for 1 h, the viable cell counting decreased 
from 9.13 to 8.40 log cfu/mL, confirming the bacteri-
cidal mode of action with cell lysis and enzyme leakage 
reported by Todorov et al. (2011). Taking into account 
that the US Food and Drug Administration and other 
food safety organizations recommend a zero-tolerance 
level (Archer, 2018) or an upper limit of 100 cfu/25 g 
for Listeria in ready-to-eat foods (Swaminathan and 
Gerner-Smidt, 2007; Voysey and Betts, 2017) and that 
such a high L. innocua contamination level is very 
unlikely to occur in foods, the almost 1 log reduction 
observed here would be of great significance from a 
public health standpoint.
Purification of Bacteriocin ST16 Obtained  
in MRS Broth and in Supplemented  
Whey Powder Formulation
The CFS of the supplemented whey powder fer-
mented by Lb. plantarum ST16Pa in bioreactor as well 
as that obtained in MRS broth, taken as a control, 
were submitted to a purification protocol with the aim 
to increase bacteriocin ST16 antimicrobial activity. To 
this purpose, both CFS were first concentrated by add-
ing 30% (wt/vol) ammonium sulfate and then loaded 
on a previously activated C18 SPE Oasis HLB cartridge 
using 40% isopropanol in 25 mM ammonium acetate 
buffer (pH 6.5) as an eluent. Table 4 summarizes the 
results of bacteriocin ST16Pa antimicrobial activity, 
total antimicrobial activity, specific activity, yield, and 
purification fold either in both CFS or after each of 
these purification steps.
The proposed purification protocol was effective 
in the purification of bacteriocin ST16Pa produced 
in MRS broth. After the final SPE step, despite the 
Figure 4. Growth of the bioindicator strain Listeria innocua 6a CLIST 2865 in the presence of bacteriocin ST16Pa (dotted line) and con-
trol without bacteriocin ST6Pa (continuous line). Error bars, corresponding to SD (n = 2), are smaller than the size of markers. OD = optical 
density.
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low yield (only 3%), the purification fold did in fact 
increase up to 13.71. On the other hand, the same pro-
tocol failed in the purification of bacteriocin produced 
in supplemented whey powder formulation (2% yield 
and purification fold decrease to 0.07), likely due to its 
130% higher content of total proteins compared with 
the fermented MRS broth, thus requiring additional 
preliminary purification steps or even a different purifi-
cation protocol. Garsa et al. (2014), using supplemented 
cheese whey to produce pediocin PA-1, proposed its 
purification by an aqueous two-phase system (ATPS) 
followed by ultrafiltration step. After the ATPS extrac-
tion, the authors achieved a 320% increase in pediocin 
PA-1 yield, which was further increased to 384% at the 
end of the ultrafiltration step; the purification fold was 
4 and 7.3, respectively. These results might have been 
due to removal of protein contaminants responsible for 
suppression of pediocin PA-1 antimicrobial activity 
or its inactivation. Likewise, Sabo et al. (2018), using 
ATPS for bacteriocin partitioning from clarified broth 
of Lb. plantarum ST16Pa, demonstrated the potential 
of this system as an initial step for bacteriocin recov-
ery and purification. Considering that this strain is 
the same used in the present work, using ATPS as a 
prepurification step may be a promising alternative to 
achieve the bacteriocin purification from supplemented 
whey powder.
CONCLUSIONS
Although the PB experimental design used in this 
work may have not been the best statistical tool to 
optimize bacteriocin ST16Pa production by Lb. plan-
tarum ST16Pa in shake flasks because it is not able to 
point out the possible combined effects of multiple vari-
ables, it allowed the identification of a supplemented 
whey powder formulation whose fermentation ensured 
an increased antimicrobial activity compared with a 
previous attempt in cheese whey. A culture performed 
in bioreactor using the best whey powder formulation 
under the same conditions as those used in shake flasks 
showed almost the same fermentation parameters and 
bacteriocin antimicrobial activity against L. innocua 
6a CLIST 2865. The attempt to purify bacteriocin 
ST16Pa by preliminary precipitation with ammonium 
sulfate and subsequent SPE was effective on the cell-
free supernatant from the fermented MRS broth taken 
as a control but failed with the CFS from fermented 
whey powder formulation, likely because of a much 
higher level of contaminating proteins. Therefore, the 
next effort in this direction will be the addition to the 
purification protocol of a step of liquid-liquid extrac-
tion by ATPS that already proved to be very efficient 
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